- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04972357
Bariatric Procedures and Changes Gastric Passage (BIP)
Bariatric Procedures and Changes in Gut Hormone and Gastric Passage
Study Overview
Status
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Arnhem, Netherlands
- Rijnstate Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Female patients who underwent S-RYGB, B-RYGB or E-RYGB as a primary bariatric surgery.
Exclusion Criteria:
(1) had a disease known to affect appetite, gastric emptying or gastrointestinal motility (e.g., diabetes mellitus or hyper-/hypothyroidism); (2) were unable to stop medications that affect gastric emptying and/or motility three days prior to measurements (e.g., anti-cholinergic drugs, prokinetics, theophylline, calcium blocking agents, opioids); (3) started menopause; (4) were pregnant or lactating; (5) had a drug or alcohol addiction; (6) were unable to stop smoking for 24 hours.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Standard RYGB
|
Banded RYGB
|
Extended pouch RYGB
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Gastric emptying rate
Time Frame: cross-sectional study. Measured once over a period of 45-60 minutes
|
cross-sectional study. Measured once over a period of 45-60 minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2018-1172 (Other Identifier: M D Anderson Cancer Center)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Roux-en-Y Gastric Bypass
-
Medtronic - MITGCompleted
-
Olympus Corporation of the AmericasUnity Health TorontoCompleted
-
Wageningen UniversityRijnstate HospitalUnknownRoux-en-Y Gastric BypassNetherlands
-
North Dakota State UniversityNeuropsychiatric Research Institute, Fargo, North DakotaCompletedRoux en Y Gastric BypassUnited States
-
North Dakota State UniversityNational Institutes of Health (NIH)CompletedRoux en Y Gastric Bypass SurgeryUnited States
-
Mayo ClinicCompletedRoux-en-Y Gastric Bypass | Gastric Bypass | Bariatric SurgeryUnited States
-
North Dakota State UniversityNeuropsychiatric Research Institute, Fargo, North DakotaCompletedSleeve Gastrectomy | Roux en Y Gastric BypassUnited States
-
Rijnstate HospitalCompleted
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedRoux-en-Y Gastric Bypass | Bariatric Surgery | Vertical Sleeve Gastrectomy | Gastric Banding | Bypass, GastricUnited States
-
CARLOS ZERRWECK LOPEZCompletedRoux-en-Y Gastric Bypass | Bariatric Surgery | Metabolic SurgeryMexico